PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Ns3 3,189 Target Disease Yellow Fever 4,081 72 0.02 -0.98 0.02 0.72
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target B2M 677 40 0.02 -0.97 0.06 0.70
CD4 112,219 Target Disease Arthritis 128,324 2,405 0.02 -0.98 0.02 0.63
CXCL16 341 Target Target CCL3 1,427 14 0.02 -0.97 0.04 0.73
CD154 1,512 Target Target CD137 474 17 0.02 -0.98 0.04 0.73
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
ERK2 3,287 Target Target EGF 27,487 191 0.02 -0.97 0.06 0.68
Epidermal Growth Factor Receptor 24,772 Target Disease Skin Rash 3,684 192 0.02 -0.97 0.05 0.68
APOE 12,771 Target Disease Hyperlipoproteinemia 2,954 124 0.02 -0.97 0.04 0.69
AFP 9,751 Target Disease Down Syndrome 10,290 203 0.02 -0.98 0.02 0.70
ANGPTL4 289 Target Target ADRP 537 8 0.02 -0.98 0.03 0.75
CXCL16 341 Target Target CCL18 256 6 0.02 -0.98 0.02 0.76
EGF 27,487 Target Disease Breast Cancer 173,695 1,411 0.02 -0.97 0.05 0.63
CCL18 256 Target Target CXCL10 2,386 16 0.02 -0.96 0.06 0.72
CA 72-4 184 Target Target CA 50 1,293 10 0.02 -0.97 0.05 0.73
Androgen Receptor 12,918 Target Disease Benign Prostatic Hyperplasia 10,026 234 0.02 -0.98 0.02 0.70
AMBP 160 Target Target A1M 59 2 0.02 -0.98 0.03 0.77
A1AT 329 Target Target Elastase 13,875 44 0.02 -0.93 0.13 0.69
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74
Angiotensin Converting Enzyme 31,674 Target Disease Heart Disease 118,291 1,274 0.02 -0.97 0.04 0.64
CXCL9 1,016 Target Target CXCL4/PF4 9 2 0.02 -0.88 0.22 0.72
CCL14 34 Target Target CXCL10 2,386 6 0.02 -0.91 0.18 0.71
Aldosterone Receptor 528 Target Drug Drospirenone 514 11 0.02 -0.98 0.02 0.76
C5a 4,164 Target Disease Inflammation 252,734 685 0.02 -0.91 0.16 0.63
CXCL7 76 Target Target CXCL10 2,386 9 0.02 -0.94 0.12 0.72
CXCL9 1,016 Target Target CCL1 220 10 0.02 -0.97 0.05 0.74
CXCL11 526 Target Target Beta-R1 38 3 0.02 -0.96 0.08 0.74
CCL7 274 Target Target CCL21 808 10 0.02 -0.98 0.04 0.74
CXCL7 76 Target Target CCL3 1,427 7 0.02 -0.95 0.09 0.73
CD4 112,219 Target Drug Abacavir 1,496 276 0.02 -0.90 0.18 0.65
Antithrombin 13,773 Target Target Bivalirudin 891 75 0.02 -0.95 0.08 0.69
ERBB3 1,154 Target Target beta-Cellulin 17 3 0.02 -0.91 0.18 0.72
BMP-14 14 Target Target BMP-2 3,889 5 0.02 -0.80 0.36 0.70
DDR2 194 Target Target Collagen 138,882 113 0.02 -0.65 0.58 0.65
CEA 17,022 Target Disease Lung Cancer 91,416 862 0.02 -0.97 0.05 0.65
Collagen 138,882 Target Target bFGF 9,327 791 0.02 -0.95 0.08 0.64
Myeloperoxidase 16,181 Target Target Xanthine Oxidase 8,860 264 0.02 -0.98 0.03 0.69
CCL18 256 Target Target CCL8 197 5 0.02 -0.98 0.03 0.77
AFP 9,751 Target Target CA 15-3 898 66 0.02 -0.96 0.07 0.70
ATAC 239 Target Disease Breast Cancer 173,695 144 0.02 -0.63 0.60 0.65
CXCL7 76 Target Target Eotaxin-3/CCL26 26 1 0.02 -0.97 0.04 0.78
CCL19 658 Target Target Exodus-2 27 3 0.02 -0.94 0.11 0.74
Histamine H1 Receptor 1,170 Target Target Histamine H4 Receptor 168 10 0.02 -0.97 0.06 0.74
Tissue-Type Plasminogen Activator 5,020 Target Drug Alteplase (Activase)- FDA 112 17 0.02 -0.92 0.15 0.71
Tissue-Type Plasminogen Activator 5,020 Target Drug Activase (Alteplase)- FDA 112 17 0.02 -0.92 0.15 0.71
CD95 4,266 Target Target Apo I 55 11 0.02 -0.89 0.20 0.71
EGF 27,487 Target Target aFGF 899 113 0.02 -0.93 0.13 0.68
Endostatin 1,599 Target Target Collagen 138,882 339 0.02 -0.89 0.21 0.65
CXCL16 341 Target Target CCL7 274 7 0.02 -0.98 0.03 0.77
Dihydropteroate Synthase 408 Target Disease Malaria 56,215 110 0.02 -0.85 0.27 0.67